- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-04-0021932

Syndac Laboratories Private Limited
About Syndac Laboratories Private Limited
Data last updated:
Syndac Laboratories Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 28 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2018PTC330175. Its GSTIN is 07AAZCS9150K1ZF (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Afzal Ahmed and Naveen Pandey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kh. No.13/25 Back Portion Ground Floor C – 12 Gali No. – 6 Nathu Colony Nathupura, New Delhi, Delhi, India – 110084.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.67 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹19,291 (net margin 1.5%) and EBITDA of ₹42,109 (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 27% over five years.
Syndac Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-04-0021932).
Company details
Recognitions & Rankings of Syndac Laboratories
Contact details
Syndac Laboratories Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressKh. No.13/25 Back Portion Ground Floor C – 12 Gali No. – 6 Nathu Colony Nathupura, New Delhi, Delhi, India – 110084
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Syndac Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Syndac Laboratories is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Syndac Laboratories Private Limited, buy the company report.
Financials of Syndac Laboratories Private Limited
FY 2025 filings availableSyndac Laboratories Private Limited reported revenue of ₹12.67 Lakh (up 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 1% growth in the latest year. EBITDA fell 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹42,109 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19,291 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Syndac Laboratories Private Limited, buy the company report.
Board of directors of Syndac Laboratories Private Limited
Syndac Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Afzal Ahmed | Director | 28 Feb 2018 | 8 Years 7 Months | Current |
| Naveen Pandey | Director | 28 Feb 2018 | 8 Years 7 Months | Current |
Peer comparison
Syndac Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mayura PVD Coatings Private Limited | ₹12.92 Lakh (FY 2024) | Ahmedabad, Gujarat, India | ||||
| Navkarma Ayurveda Private Limited | ₹12.69 Lakh (FY 2025) | Jodhpur, Rajasthan, India | ||||
| Livras Lifesciences Private Limited | ₹12.68 Lakh (FY 2025) | 54.0% | Delhi, India | |||
| Aadvika Lifeline Private Limited | ₹12.67 Lakh (FY 2024) | Noida, Uttar Pradesh, India | ||||
| Ultichem Pharmaceuticals Private Limited | ₹12.67 Lakh (FY 2024) | 11.0% | Delhi, India | |||
| Syndac Laboratories Private Limitedthis company | ₹12.67 Lakh (FY 2025) | ₹19,291 | 1.5% | 1.0% | New Delhi, Delhi, India | |
| Edulakanti Pharmaceuticals Private Limited | ₹12.66 Lakh (FY 2025) | -64.0% | Hyderabad, Telangana, India | |||
| Vitabiotics (India ) Private Limited | ₹12.58 Lakh (FY 2025) | 14.0% | Thane, Maharashtra, India | |||
| Endolax Medicare Private Limited | ₹12.51 Lakh (FY 2024) | New Delhi, Delhi, India | ||||
| Rashika Medicare Private Limited | ₹12.39 Lakh (FY 2025) | 106.0% | Gurgaon, Haryana, India | |||
| Safewin Pharma Private Limited | ₹12.25 Lakh (FY 2025) | 553.0% | Agra, Uttar Pradesh, India |
To see the full peer comparison of Syndac Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Syndac Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Syndac Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Syndac Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAZCS9150K1ZF | Delhi | Active | 28 Jun 2019 |
To see the full GST registrations and return filing status of Syndac Laboratories Private Limited, buy the company report.
Recent activity
Syndac Laboratories Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Afzal Ahmed was appointed as Director on 28 Feb 2018.
Frequently asked questions
Syndac Laboratories is an active private limited company based in New Delhi, Delhi, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 28 February 2018 (8+ years old) and is registered under CIN U24304DL2018PTC330175.
Syndac Laboratories has 2 current directors:
- Afzal Ahmed - Director
- Naveen Pandey - Director
The latest financial statements of Syndac Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Syndac Laboratories is 07AAZCS9150K1ZF, registered in Delhi.
The CIN (Corporate Identification Number) of Syndac Laboratories is U24304DL2018PTC330175. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Syndac Laboratories was incorporated on 28 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Syndac Laboratories by revenue are Mayura PVD Coatings Private Limited, Navkarma Ayurveda Private Limited, Livras Lifesciences Private Limited, Aadvika Lifeline Private Limited, Ultichem Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Afzal Ahmed was appointed as Director on 28 Feb 2018. Naveen Pandey was appointed as Director on 28 Feb 2018.
Yes, Syndac Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-04-0021932).
The registered office of Syndac Laboratories is at Kh. No.1325 Back Portion Ground Floor C – 12 Gali No. – 6 Nathu Colony Nathupura, New Delhi, Delhi, India – 110084.
Syndac Laboratories operates in the food and beverages industry, in the artificial fibres segment.